Alignment Healthcare PE Ratio 2020-2023 | ALHC
Current and historical p/e ratio for Alignment Healthcare (ALHC) from 2020 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Alignment Healthcare PE ratio as of May 15, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Alignment Healthcare PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-05-15 | 7.05 | 0.00 | |
| 2023-12-31 | 8.61 | $-0.79 | 0.00 |
| 2023-09-30 | 6.94 | $-0.85 | 0.00 |
| 2023-06-30 | 5.75 | $-0.88 | 0.00 |
| 2023-03-31 | 6.36 | $-0.79 | 0.00 |
| 2022-12-31 | 11.76 | $-0.82 | 0.00 |
| 2022-09-30 | 11.84 | $-0.78 | 0.00 |
| 2022-06-30 | 11.41 | $-0.82 | 0.00 |
| 2022-03-31 | 11.23 | $-1.01 | 0.00 |
| 2021-12-31 | 14.06 | $-1.15 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.348B | $1.824B |
| Alignment Healthcare Inc. is a consumer-centric platform delivering customized health care in the United States to seniors and those who need it most, the chronically ill and frail, through its Medicare Advantage plans. Alignment Healthcare Inc. is based in ORANGE, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $125.503B | 15.75 |
| Cencora (COR) | United States | $44.240B | 17.25 |
| ICON (ICLR) | Ireland | $26.547B | 25.06 |
| DiDi Global (DIDIY) | China | $22.698B | 0.00 |
| Avantor (AVTR) | United States | $17.124B | 25.21 |
| CochLear (CHEOY) | Australia | $14.770B | 0.00 |
| Revvity (RVTY) | United States | $13.241B | 23.23 |
| Viatris (VTRS) | United States | $13.181B | 3.94 |
| Natera (NTRA) | United States | $13.178B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.576B | 41.37 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.562B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.979B | 22.93 |
| Solventum (SOLV) | United States | $10.784B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.628B | 0.00 |
| HealthEquity (HQY) | United States | $6.508B | 48.62 |
| Organon (OGN) | United States | $5.568B | 5.28 |
| Bausch + Lomb (BLCO) | Canada | $5.269B | 21.11 |
| Doximity (DOCS) | United States | $4.449B | 33.12 |
| PACS (PACS) | United States | $4.257B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.440B | 31.48 |
| Sotera Health (SHC) | United States | $3.230B | 15.85 |
| Life Times (LTH) | United States | $2.979B | 31.21 |
| GoodRx Holdings (GDRX) | United States | $2.728B | 103.86 |
| Progyny (PGNY) | United States | $2.550B | 43.90 |
| Premier (PINC) | United States | $2.383B | 8.92 |
| AMN Healthcare Services Inc (AMN) | United States | $2.287B | 9.06 |
| NovoCure (NVCR) | Jersey | $2.265B | 0.00 |
| Agilon Health (AGL) | United States | $2.180B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.172B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.992B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.647B | 0.00 | |
| Embecta (EMBC) | United States | $0.793B | 5.39 |
| CareDx (CDNA) | United States | $0.770B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
| Pediatrix Medical (MD) | United States | $0.690B | 7.32 |
| Auna S.A (AUNA) | Luxembourg | $0.648B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.566B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.553B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.544B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.456B | 0.00 |
| Enhabit (EHAB) | United States | $0.434B | 43.30 |
| MultiPlan (MPLN) | United States | $0.405B | 0.00 |
| ModivCare (MODV) | United States | $0.382B | 7.15 |
| LifeMD (LFMD) | United States | $0.351B | 0.00 |
| DocGo (DCGO) | United States | $0.350B | 18.67 |
| Beauty Health (SKIN) | United States | $0.342B | 0.00 |
| Sharecare (SHCR) | United States | $0.275B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.273B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.267B | 0.00 |
| Biodesix (BDSX) | United States | $0.175B | 0.00 |
| So-Young (SY) | China | $0.124B | 41.67 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
| Oncology Institute (TOI) | United States | $0.051B | 0.00 |
| NeueHealth (NEUE) | United States | $0.051B | 6.84 |
| Nutex Health (NUTX) | United States | $0.036B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.035B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.028B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.026B | 0.00 |
| OncoCyte (OCX) | United States | $0.024B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.024B | 0.00 |
| DermTech (DMTK) | United States | $0.020B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |